These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20065628)

  • 1. mAb therapeutic products and risk management.
    Reichert JM
    MAbs; 2010; 2(1):1-2. PubMed ID: 20065628
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in regulations for approval of therapeutics.
    Reichert JM
    MAbs; 2010; 2(4):359-60. PubMed ID: 25225706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genentech and IDEC await approval of lymphoma Mab.
    Nat Biotechnol; 1997 Apr; 15(4):301. PubMed ID: 9094110
    [No Abstract]   [Full Text] [Related]  

  • 5. PDL's mAb technology finds right timing.
    Fletcher L
    Nat Biotechnol; 2001 May; 19(5):395-6. PubMed ID: 11328982
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies: production, uses and side effects.
    Cowden J; Parker SK
    Pediatr Infect Dis J; 2006 Jun; 25(6):553-5. PubMed ID: 16732156
    [No Abstract]   [Full Text] [Related]  

  • 7. Hazard identification and risk assessment for biologics targeting the immune system.
    Weir AB
    J Immunotoxicol; 2008 Jan; 5(1):3-10. PubMed ID: 18382852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.
    An Z
    Protein Cell; 2010 Apr; 1(4):319-330. PubMed ID: 21203944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining appropriate use of antibiotics.
    Gums JG
    Am Fam Physician; 2004 Jan; 69(1):35, 39-40. PubMed ID: 14727818
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology. Go-ahead for Centocor.
    Gershon D
    Nature; 1991 Sep; 353(6340):101. PubMed ID: 1891035
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions.
    Rodgers KR; Chou RC
    Biotechnol Adv; 2016 Nov; 34(6):1149-1158. PubMed ID: 27460206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal and engineered antibodies for human parenteral clinical use: regulatory considerations.
    Manohar V; Hoffman T
    Trends Biotechnol; 1992 Sep; 10(9):305-9. PubMed ID: 1369087
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibodies: clinical and regulatory issues.
    Thorpe R
    Trends Biotechnol; 1993 Feb; 11(2):40-2. PubMed ID: 7765291
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical considerations in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy.
    Bogard WC; Dean RT; Deo Y; Fuchs R; Mattis JA; McLean AA; Berger HJ
    Semin Nucl Med; 1989 Jul; 19(3):202-20. PubMed ID: 2669129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies as innovative therapeutics.
    Reichert JM
    Curr Pharm Biotechnol; 2008 Dec; 9(6):423-30. PubMed ID: 19075682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercial development considerations for biotechnology-derived therapeutics.
    Marafino BJ; Pugsley MK
    Cardiovasc Toxicol; 2003; 3(1):5-12. PubMed ID: 12668886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA urged to reduce REMS program burdens.
    Traynor K
    Am J Health Syst Pharm; 2015 Nov; 72(22):1916-21. PubMed ID: 26541942
    [No Abstract]   [Full Text] [Related]  

  • 19. Points to consider in the manufacture and testing of monoclonal antibody products for human use (1997). U.S. Food and Drug Administration Center for Biologics Evaluation and Research.
    J Immunother; 1997 May; 20(3):214-43. PubMed ID: 9181460
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.